Yuxin Zhao

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Crystalline forms of a somatostatin modulator
- Patent number 11,773,076
- Issue date Oct 3, 2023
- CRINETICS PHARMACEUTICALS, INC.
- Yuxin Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for the preparation of uracil derivatives
- Patent number 11,459,305
- Issue date Oct 4, 2022
- Neurocrine Biosciences, Inc.
- Donald J. Gallagher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Processes for the preparation of uracil derivatives
- Patent number 10,494,347
- Issue date Dec 3, 2019
- Neurocrine Biosciences, Inc.
- Donald J. Gallagher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline form of 1-(1-methyl-1H-pyrazol-4-yl)-N-((IR,5S,7S)-9-me...
- Patent number 10,329,306
- Issue date Jun 25, 2019
- Takeda Pharmaceutical Company Limited
- Yuxin Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for the preparation of uracil derivatives
- Patent number 9,868,706
- Issue date Jan 16, 2018
- Neurocrine Biosciences, Inc.
- Donald J. Gallagher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for the preparation of uracil derivatives
- Patent number 9,382,214
- Issue date Jul 5, 2016
- Neurocine Biosciences, Inc.
- Donald J. Gallagher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processes for the preparation of uracil derivatives
- Patent number 8,765,948
- Issue date Jul 1, 2014
- Neurocrine Biosciences, Inc.
- Donald J. Gallagher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for making (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-flouro...
- Patent number 8,436,200
- Issue date May 7, 2013
- Takeda Pharmaceutical Company Limited
- David Paul Provencal
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CRYSTALLINE MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONIST
- Publication number 20240208963
- Publication date Jun 27, 2024
- Crinetics Pharmaceuticals, Inc.
- Yuxin ZHAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF SOMATOSTATIN MODULATORS
- Publication number 20220267295
- Publication date Aug 25, 2022
- Crinetics Pharmaceuticals, Inc.
- Jayachandra P. REDDY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF A SOMATOSTATIN MODULATOR
- Publication number 20220259175
- Publication date Aug 18, 2022
- Crinetics Pharmaceuticals, Inc.
- Yuxin ZHAO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES
- Publication number 20200255387
- Publication date Aug 13, 2020
- Neurocrine Biosciences, Inc.
- Donald J. Gallagher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES
- Publication number 20190218191
- Publication date Jul 18, 2019
- Neurocrine Biosciences, Inc.
- Donald J. Gallagher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES
- Publication number 20180346428
- Publication date Dec 6, 2018
- Neurocrine Biosciences, Inc.
- Donald J. Gallagher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES
- Publication number 20170320836
- Publication date Nov 9, 2017
- Neurocrine Biosciences, Inc.
- Donald J. Gallagher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORM OF 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-ME...
- Publication number 20170233406
- Publication date Aug 17, 2017
- Takeda Pharmaceutical Company Limited
- Yuxin Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES
- Publication number 20150018553
- Publication date Jan 15, 2015
- Neurocrine Biosciences, Inc.
- Donald J. Gallagher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR MAKING (R) -3-(2,3-DIHYDROXYPROPYL)-6-FLUORO-5-(2-FLOUR...
- Publication number 20130225813
- Publication date Aug 29, 2013
- Takeda Pharmaceutical Company Limited
- David Paul Provencal
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR MAKING (R) -3-(2,3-DIHYDROXYPROPYL)-6-FLUORO-5-(2-FLOUR...
- Publication number 20120264967
- Publication date Oct 18, 2012
- Takeda Pharmaceutical Company Limited
- David Paul Provencal
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES
- Publication number 20110098472
- Publication date Apr 28, 2011
- Neurocrine Biosciences, Inc.
- Donald J. Gallagher
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR MAKING (R)-3-(2,3-DIHYDROXYPROPYL)-6-FLUORO-5-(2-FLOURO...
- Publication number 20100125138
- Publication date May 20, 2010
- Takeda Pharmaceutical Company Limited
- David Paul Provencal
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Crystalline forms of a somatostatin modulator

Processes for the preparation of uracil derivatives

Processes for the preparation of uracil derivatives

Crystalline form of 1-(1-methyl-1H-pyrazol-4-yl)-N-((IR,5S,7S)-9-me...

Processes for the preparation of uracil derivatives

Processes for the preparation of uracil derivatives

Processes for the preparation of uracil derivatives

Process for making (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-flouro...

Patents Applicationslast 30 patents

CRYSTALLINE MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONIST

CRYSTALLINE FORMS OF SOMATOSTATIN MODULATORS

CRYSTALLINE FORMS OF A SOMATOSTATIN MODULATOR

PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES

PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES

PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES

PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES

CRYSTALLINE FORM OF 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-ME...

PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES

PROCESS FOR MAKING (R) -3-(2,3-DIHYDROXYPROPYL)-6-FLUORO-5-(2-FLOUR...

PROCESS FOR MAKING (R) -3-(2,3-DIHYDROXYPROPYL)-6-FLUORO-5-(2-FLOUR...

PROCESSES FOR THE PREPARATION OF URACIL DERIVATIVES

PROCESS FOR MAKING (R)-3-(2,3-DIHYDROXYPROPYL)-6-FLUORO-5-(2-FLOURO...